Janux Therapeutics, Inc. (JANX)
14.12
+0.03
(+0.21%)
USD |
NASDAQ |
Dec 23, 16:00
14.13
+0.01
(+0.07%)
After-Hours: 20:00
Janux Therapeutics SG&A Expense (TTM): 39.13M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Stoke Therapeutics, Inc. | 58.79M |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| MannKind Corp. | 195.42M |
| Editas Medicine, Inc. | 54.90M |
| Vera Therapeutics, Inc. | 80.89M |